butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers could lower sufentanil degrees and efficacy, potentially precipitating withdrawal syndrome in sufferers who definitely have designed Actual physical dependence to s